Thubilux Pharma SpA has received a structured loan of US$2.7 million from a leading Italian bank
Tubilux Pharma SpA has successfully raised funds through a structured loan from Cassa Depositi e Prestiti SpA and Banca Intesa San Paolo SpA to support an investment plan for a new production facility which has all the FDA requirements to enter the USA market.
Tubilux Pharma is a leading, privately-held ophthalmic and pharmaceuticals company that develops and markets a range of proprietary, over-the-counter, and branded generic products, with distribution in approximately 30 countries. The firm's customers are large multinational pharmaceutical companies that outsource their production of ophthalmic products to specialized manufactures through medium-term supply contracts (3-5 years).
Oaklins' team in Italy advised Thubilux Pharma SpA in the structuring, negotiation and closing of a long-term debt financing from a leading Italian bank, backed by Cassa Depositi e Prestiti.
Talk to the deal team
Marie Gabriella Sestini
Navitas Petroleum has issued bonds worth US$117 million
Navitas Petroleum has completed a fundraising to to refinance and develop the company.Learn more
Laptaria cu Caimac has raised growth capital
Laptaria cu Caimac has raised US$3.5 million via a corporate bond private placement that has attracted strong interest both from high-net-worth individuals and institutional investors.Learn more
Global Media Santé has been acquired by SFP Expansion
Global Media Santé’s CEO, Alain Trébucq, and Apax Partners have sold the company to SFP Expansion Group.Learn more